Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
Open Access
- 9 July 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (11) , 1682-1688
- https://doi.org/10.1038/sj.bjc.6690584
Abstract
Prepubertal exposure to a pharmacological dose (500 mg kg–1) of the phyto-oestrogen genistein can reduce the incidence and multiplicity of carcinogen-induced mammary tumours in rats. However, such an exposure also disrupts the function of the hypothalamic–pituitary–gonadal axis, making it unsuitable for breast cancer prevention. We studied whether prepubertal exposure to genistein at a total body dose broadly comparable to the level typical of Oriental countries, approximately 1 mg kg–1 body weight, affects mammary tumorigenesis. We also studied whether prepubertal exposure to zearalenone, a major source for phyto-oestrogens in the USA, influences breast cancer risk. Prepubertal rats were treated between postnatal days 7 and 20, with 20 μg (~ 1 mg kg–1 body weight) of either genistein or zearalenone. Zearalenone exposure significantly reduced both the incidence and multiplicity of mammary tumours induced by 7,12-dimethylbenz(a)anthracene (DMBA). Genistein exposure significantly reduced tumour multiplicity, but not tumour incidence, when compared with vehicle-treated animals. Furthermore, 60% of the tumours in the genistein group were not malignant, while all the tumours analysed for histopathology in the vehicle and zearalenone groups were adenocarcinomas. A higher number of differentiated alveolar buds, and lower number of terminal ducts, were present in the DMBA-treated mammary glands of the phyto-oestrogen exposed rats. The concentration of oestrogen receptor (ER) binding sites after the DMBA treatment was low in the mammary glands of all groups but a significantly higher proportion of the glands in the zearalenone exposed rats were ER-positive (i.e. ER levels ≥ 5 fmol mg–1 protein) than the glands of the vehicle controls. Our data suggest that a prepubertal exposure to a low dose of either zearalenone or genistein may protect the mammary gland from carcinogen-induced malignant transformation, possibly by increasing differentiation of the mammary epithelial tree.Keywords
This publication has 62 references indexed in Scilit:
- Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Carcinogenesis by Soy Foods or Biochanin AJapanese Journal of Cancer Research, 1998
- Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cellsin vitroNutrition and Cancer, 1997
- Perinatal Factors and Risk of Breast CancerEpidemiology, 1996
- Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?Carcinogenesis: Integrative Cancer Research, 1995
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Hormonal aspects of breast cancer: Growth factors, drugs and stromal interactionsCritical Reviews in Oncology/Hematology, 1992
- Effects of perinatal exposure to a synthetic estrogen and progestin on mammary tumorigenesis in miceTeratology, 1988
- The effects of Mg2+ ions or EDTA on nuclear integrity and apparent subcellular distribution of unoccupied oestrogen receptors in breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Incidence, growth and oestradiol-receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in rats: effects of neonatal sex steroids and oestradiol implantsJournal of Endocrinology, 1982
- Characterization, geographic distribution and ecology of Fusarium crookwellense sp.nov.Transactions of the British Mycological Society, 1982